Diversified Healthcare Trust (DHC) EBITDA (2009 - 2026)

Diversified Healthcare Trust's EBITDA history runs 18 years deep, the most recent figure standing at -$75.9 million for Q1 2026.

• Quarterly EBITDA fell 35.24% year-over-year to -$75.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$331.1 million (up 10.99% YoY) and the FY2025 annual result came in at -$252.5 million, up 43.22% from the prior year.
• EBITDA was -$75.9 million for Q1 2026 at Diversified Healthcare Trust, down from -$25.5 million in the prior quarter.
• Across five years, EBITDA topped out at $295.7 million in Q1 2022 and bottomed at -$179.0 million in Q3 2025.
• A 5-year average of -$40.4 million and a median of -$36.7 million in 2022 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2022 — EBITDA jumped 5150.77% — and 2024, when it tumbled 2031.6%.
• Diversified Healthcare Trust's EBITDA stood at -$13.5 million in 2022, then plunged by 130.22% to -$31.0 million in 2023, then tumbled by 432.25% to -$165.2 million in 2024, then soared by 84.55% to -$25.5 million in 2025, then slumped by 197.26% to -$75.9 million in 2026.
• Business Quant data shows DHC's EBITDA at -$75.9 million in Q1 2026, -$25.5 million in Q4 2025, and -$179.0 million in Q3 2025.